relat debt extinguish
sale ahead our/street
estim higher us/int omnipod sale guidanc y/i
consensus/u previous lower us omnipod manag
note tougher comp follow anniversari move dash
drug deliveri guidanc line manag note on-going dash
momentum pharmaci channel initi drive us growth also
tailwind almost new us omnipod user continu target
launch horizon year-end manag expect materi impact
addit initi focu includ on-going intern expans ramp
autom manufactur facil product impact expect begin
us omnipod sale top estim mainli
higher new custom growth total us-custom base
receiv pod pharmaci us omnipod
sale expect reflect continu dash volum growth
product adopt type market
ous/drug-deliveri ou sale slightli ahead
estim manag guid ou sale includ fx
headwind aim expand new countri within europ middl east
drug deliveri sale beat estim management guid
sale declin base updat partner forecast
pipelin updat horizon pivot trial complet enrol
individu includ pediatr pivot data like avail summer
manag continu target launch yer-end limit launch dash
select european market underway broader roll-out across europ
canada expect management note collabor still earli
note ramp first us autom manufactur line
product sellabl product second line expect midyear third
manufactur line target later year product ramp expect
weigh gm management continu target gm management
seeing/expect impact coronaviru china manufactur
estim guidanc lower sale estim slightli
y/i ep estim lower lower
sale lower gm new manufactur line ramp forecast sale
ep roll pt pt rise
year price histori
market insulin infus system
peopl
diabet primari product
analyst certif import disclosur see disclosur
omnipod tubeless insulin pump uniqu offer
diabet pump space compani sever
opportun ahead includ entranc medicare/
medicaid popul dash next gener platform
provid entri pharmaci channel horizon
autom glucos control system combin
cgm track year-end launch rate perform
valuat
growth us market
long-term gross margin
omnipod dash roll-out europ canada
horizon target launch year-end
greater expect gross margin expans quicker sale
expans new countri
slowdown market share gain competitor hybrid close loop
launch ahead horizon
price target driven discount cash flow analysi ev/sal multipl analysi dcf assum
weight averag cost capit wacc termin growth rate estim ebitda pt
impli sale estim line peer current year multipl
sale market
gener administr
sale market
gener administr
sale market
gener administr
footnot includ one-tim non-cash charg relat debt extinguish
footnot includ one-tim non-cash charg relat debt extinguish
stock price compani mention report
